Annual Shareholders Equity
$996.52 M
-$400.52 M-28.67%
December 31, 2022
Summary
- As of February 11, 2025, MRTX annual stockholders equity is $996.52 million, with the most recent change of -$400.52 million (-28.67%) on December 31, 2022.
- During the last 3 years, MRTX annual shareholders equity has risen by +$614.22 million (+160.67%).
Performance
MRTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$946.47 M
+$217.51 M+29.84%
September 30, 2023
Summary
- As of February 11, 2025, MRTX quarterly stockholders equity is $946.47 million, with the most recent change of +$217.51 million (+29.84%) on September 30, 2023.
- Over the past year, MRTX quarterly shareholders equity has dropped by -$182.59 million (-16.17%).
Performance
MRTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MRTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.7% | -16.2% |
| 3 y3 years | +160.7% | +71.8% |
| 5 y5 years | +595.5% | +320.5% |
MRTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.7% | at low | -32.3% | -23.0% |
| 5 y | 5-year | -28.7% | -61.6% | -32.3% | -59.6% |
| alltime | all time | -28.7% | -99.6% | -32.3% | -102.5% |
Mirati Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $946.47 M(+29.8%) |
| Jun 2023 | - | $728.95 M(-15.5%) |
| Mar 2023 | - | $862.63 M(-13.4%) |
| Dec 2022 | $996.52 M(-28.7%) | $996.52 M(-11.7%) |
| Sep 2022 | - | $1.13 B(+1.5%) |
| Jun 2022 | - | $1.11 B(-11.0%) |
| Mar 2022 | - | $1.25 B(-10.6%) |
| Dec 2021 | $1.40 B(+2.7%) | $1.40 B(+28.9%) |
| Sep 2021 | - | $1.08 B(-4.0%) |
| Jun 2021 | - | $1.13 B(-10.4%) |
| Mar 2021 | - | $1.26 B(-7.4%) |
| Dec 2020 | $1.36 B(+256.0%) | $1.36 B(+147.0%) |
| Sep 2020 | - | $550.94 M(-8.9%) |
| Jun 2020 | - | $605.00 M(-7.8%) |
| Mar 2020 | - | $656.23 M(+71.7%) |
| Dec 2019 | $382.30 M(+89.7%) | $382.30 M(-12.0%) |
| Sep 2019 | - | $434.49 M(-8.0%) |
| Jun 2019 | - | $472.48 M(+66.6%) |
| Mar 2019 | - | $283.55 M(+40.7%) |
| Dec 2018 | $201.58 M(+40.7%) | $201.58 M(-10.4%) |
| Sep 2018 | - | $225.09 M(-8.6%) |
| Jun 2018 | - | $246.34 M(+78.7%) |
| Mar 2018 | - | $137.84 M(-3.8%) |
| Dec 2017 | $143.29 M(+196.6%) | $143.29 M(+110.2%) |
| Sep 2017 | - | $68.15 M(-17.9%) |
| Jun 2017 | - | $82.97 M(-16.3%) |
| Mar 2017 | - | $99.12 M(+105.2%) |
| Dec 2016 | $48.31 M(-59.1%) | $48.31 M(-26.2%) |
| Sep 2016 | - | $65.48 M(-20.3%) |
| Jun 2016 | - | $82.18 M(-19.2%) |
| Mar 2016 | - | $101.65 M(-14.0%) |
| Dec 2015 | $118.18 M(+321.1%) | $118.18 M(-11.7%) |
| Sep 2015 | - | $133.86 M(+144.6%) |
| Jun 2015 | - | $54.72 M(-18.4%) |
| Mar 2015 | - | $67.05 M(+138.9%) |
| Dec 2014 | $28.06 M | $28.06 M(-21.5%) |
| Sep 2014 | - | $35.74 M(+640.7%) |
| Jun 2014 | - | $4.83 M(-64.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $13.59 M(-47.5%) |
| Dec 2013 | $25.89 M(-24.8%) | $25.89 M(-209.9%) |
| Sep 2013 | - | -$23.56 M(-477.8%) |
| Jun 2013 | - | $6.24 M(-76.3%) |
| Mar 2013 | - | $26.29 M(-23.6%) |
| Dec 2012 | $34.42 M(+26.5%) | $34.42 M(+123.6%) |
| Sep 2012 | - | $15.39 M(-23.0%) |
| Jun 2012 | - | $19.98 M(-19.6%) |
| Mar 2012 | - | $24.85 M(-8.6%) |
| Dec 2011 | $27.20 M(+570.0%) | $27.20 M(-9.3%) |
| Sep 2011 | - | $30.00 M(-13.5%) |
| Jun 2011 | - | $34.67 M(+1251.2%) |
| Mar 2011 | - | $2.57 M(-36.8%) |
| Dec 2010 | $4.06 M(-66.0%) | $4.06 M(-31.1%) |
| Sep 2010 | - | $5.89 M(-43.3%) |
| Jun 2010 | - | $10.39 M(+32.6%) |
| Mar 2010 | - | $7.83 M(-34.4%) |
| Dec 2009 | $11.94 M(-58.7%) | $11.94 M(-22.5%) |
| Sep 2009 | - | $15.40 M(-18.9%) |
| Jun 2009 | - | $18.98 M(-17.0%) |
| Mar 2009 | - | $22.87 M(-20.8%) |
| Dec 2008 | $28.87 M(-36.8%) | $28.87 M(+2.4%) |
| Sep 2008 | - | $28.20 M(-13.2%) |
| Jun 2008 | - | $32.51 M(-17.1%) |
| Mar 2008 | - | $39.22 M(-14.2%) |
| Dec 2007 | $45.69 M(+10.9%) | $45.69 M(-11.7%) |
| Sep 2007 | - | $51.75 M(-3.9%) |
| Jun 2007 | - | $53.83 M(-2.0%) |
| Mar 2007 | - | $54.94 M(+33.3%) |
| Dec 2006 | $41.21 M(+70.6%) | $41.21 M(-8.4%) |
| Sep 2006 | - | $45.01 M(+6.5%) |
| Jun 2006 | - | $42.25 M(+72.4%) |
| Mar 2006 | - | $24.51 M(+1.5%) |
| Dec 2005 | $24.15 M(-31.7%) | $24.15 M(-14.4%) |
| Sep 2005 | - | $28.21 M(-5.4%) |
| Jun 2005 | - | $29.83 M(-9.7%) |
| Mar 2005 | - | $33.05 M |
| Dec 2004 | $35.36 M(+43.8%) | - |
| Dec 2003 | $24.60 M | - |
FAQ
- What is Mirati Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Mirati Therapeutics?
- What is Mirati Therapeutics annual shareholders equity year-on-year change?
- What is Mirati Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly shareholders equity year-on-year change?
What is Mirati Therapeutics annual stockholders equity?
The current annual shareholders equity of MRTX is $996.52 M
What is the all time high annual shareholders equity for Mirati Therapeutics?
Mirati Therapeutics all-time high annual stockholders equity is $1.40 B
What is Mirati Therapeutics annual shareholders equity year-on-year change?
Over the past year, MRTX annual stockholders equity has changed by -$400.52 M (-28.67%)
What is Mirati Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MRTX is $946.47 M
What is the all time high quarterly shareholders equity for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly stockholders equity is $1.40 B
What is Mirati Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MRTX quarterly stockholders equity has changed by -$182.59 M (-16.17%)